Perl Highlights Latest CAR T-Cell Therapy Advances – OncLive
OncLive |
Perl Highlights Latest CAR T-Cell Therapy Advances
OncLive OncLive: CAR T-cell therapy was recently named ASCO's Cancer Advance of the Year. How has this treatment changed the paradigm for hematologic malignancies, such as ALL? Perl: The CD19-directed therapies have really changed that process, whether it's … |
